Updated:
Onward Medical N.V./ADR
Onward Medical N.V./ADR is a publicly traded medical device company developing spinal cord stimulation therapies to restore movement after injury.
Onward Medical N.V./ADR
Onward Medical N.V. is a Netherlands-based publicly traded medical technology company, listed on the Euronext Brussels and Euronext Amsterdam exchanges, with ADR shares trading in the US. The company was founded to advance treatments for spinal cord injury, leveraging electrical stimulation and digital technologies to restore function. The company's primary research and development programs include a platform for targeted spinal cord stimulation and a separate brain-computer interface initiative. Onward Medical's approach involves both a fully implanted pulse generator system and a non-invasive external stimulation device. The company has reported preclinical and clinical data in peer-reviewed journals demonstrating motor and autonomic function recovery. It has an exclusive license agreement with the Swiss Federal Institute of Technology Lausanne (EPFL) for foundational spinal cord stimulation technology (per EPFL, 2019). Onward Medical has not publicly disclosed a headquarters city or a count of employees. The company operates as a public entity with shares available through ADR programs in the United States. No additional offices, philanthropic arms, or affiliated vehicles have been identified in public filings. As a publicly traded entity, Onward Medical's governance structure differs from that of a private family office. Its capital structure includes institutional and retail shareholders who trade on European exchanges. The company is subject to the reporting requirements of the Dutch Financial Markets Authority and, for its ADR, US SEC regulations.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
—
Country
—
City
—
Corporate office
—
Frequently asked questions
Is Onward Medical a family office or an investment firm?
No. Onward Medical N.V. is a publicly traded medical device company, not a family office or asset manager. It trades on Euronext exchanges and as an American Depositary Receipt. Its mission is to develop therapies for spinal cord injury, not to manage capital for families or institutions.
What does Onward Medical develop as a therapy?
The company develops a spinal cord stimulation system—both an implanted pulse generator and a non-invasive external device—designed to restore motor and autonomic function in people with spinal cord injury. It also has a brain-computer interface program. The technology is based on research from EPFL and is in clinical development.
Where is Onward Medical headquartered?
Public filings indicate the company is incorporated in the Netherlands and trades on Euronext Brussels and Euronext Amsterdam. No specific headquarters city has been disclosed in the available public record.
Who leads Onward Medical?
The CEO is Dave Marver, who has led the company since its early stages. The board includes directors with backgrounds in medical device commercialization, neuroscience, and public company governance—though specific named principals have not been published in easily accessible form.
How does Onward Medical relate to EPFL?
Onward Medical holds an exclusive license from the Swiss Federal Institute of Technology Lausanne (EPFL) for foundational spinal cord stimulation technology (per EPFL, 2019). The relationship is an academic–industry partnership, not an investment relationship.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: